Structure

Physi-Chem Properties

Molecular Weight:  650.25
Volume:  671.326
LogP:  7.805
LogD:  4.084
LogS:  -3.115
# Rotatable Bonds:  8
TPSA:  156.91
# H-Bond Aceptor:  9
# H-Bond Donor:  6
# Rings:  6
# Heavy Atoms:  9

MedChem Properties

QED Drug-Likeness Score:  0.104
Synthetic Accessibility Score:  4.747
Fsp3:  0.256
Lipinski Rule-of-5:  Rejected
Pfizer Rule:  Accepted
GSK Rule:  Rejected
BMS Rule:  2
Golden Triangle Rule:  Rejected
Chelating Alert:  0
PAINS Alert:  0

ADMET Properties (ADMETlab2.0)

ADMET: Absorption

Caco-2 Permeability:  -5.1
MDCK Permeability:  8.85819554241607e-06
Pgp-inhibitor:  0.186
Pgp-substrate:  0.221
Human Intestinal Absorption (HIA):  0.007
20% Bioavailability (F20%):  0.971
30% Bioavailability (F30%):  0.973

ADMET: Distribution

Blood-Brain-Barrier Penetration (BBB):  0.001
Plasma Protein Binding (PPB):  96.04010772705078%
Volume Distribution (VD):  0.559
Pgp-substrate:  1.442967176437378%

ADMET: Metabolism

CYP1A2-inhibitor:  0.101
CYP1A2-substrate:  0.446
CYP2C19-inhibitor:  0.961
CYP2C19-substrate:  0.054
CYP2C9-inhibitor:  0.936
CYP2C9-substrate:  0.993
CYP2D6-inhibitor:  0.788
CYP2D6-substrate:  0.717
CYP3A4-inhibitor:  0.42
CYP3A4-substrate:  0.179

ADMET: Excretion

Clearance (CL):  13.187
Half-life (T1/2):  0.236

ADMET: Toxicity

hERG Blockers:  0.135
Human Hepatotoxicity (H-HT):  0.932
Drug-inuced Liver Injury (DILI):  0.907
AMES Toxicity:  0.016
Rat Oral Acute Toxicity:  0.868
Maximum Recommended Daily Dose:  0.982
Skin Sensitization:  0.95
Carcinogencity:  0.086
Eye Corrosion:  0.003
Eye Irritation:  0.887
Respiratory Toxicity:  0.583

Download Data

Data Type Select
General Info & Identifiers & Properties  
Structure MOL file  
Source Organisms  
Biological Activities  
Similar NPs/Drugs  

  Natural Product: NPC473012

Natural Product ID:  NPC473012
Common Name*:   Alopecurone B
IUPAC Name:   (2R,3S,7S)-7-(2,4-dihydroxyphenyl)-3-(3,5-dihydroxyphenyl)-4-hydroxy-2-(4-hydroxyphenyl)-9-(5-methyl-2-prop-1-en-2-ylhex-4-enyl)-2,3,6,7-tetrahydrofuro[3,2-g]chromen-5-one
Synonyms:  
Standard InCHIKey:  UVQKYQGWGMUDAI-PFVCLYDRSA-N
Standard InCHI:  InChI=1S/C39H38O9/c1-19(2)5-6-22(20(3)4)15-29-38-34(31(45)18-32(47-38)28-12-11-25(41)17-30(28)44)36(46)35-33(23-13-26(42)16-27(43)14-23)37(48-39(29)35)21-7-9-24(40)10-8-21/h5,7-14,16-17,22,32-33,37,40-44,46H,3,6,15,18H2,1-2,4H3/t22?,32-,33-,37-/m0/s1
SMILES:  CC(=CCC(C(=C)C)Cc1c2O[C@@H](CC(=O)c2c(c2c1O[C@H]([C@H]2c1cc(O)cc(c1)O)c1ccc(cc1)O)O)c1ccc(cc1O)O)C
Synthetic Gene Cluster:   n.a.
ChEMBL Identifier:   CHEMBL3600405
PubChem CID:   10394489
Chemical Classification**:  
  • CHEMONTID:0000000 [Organic compounds]
    • [CHEMONTID:0000261] Phenylpropanoids and polyketides
      • [CHEMONTID:0003405] 2-arylbenzofuran flavonoids

*Note: the InCHIKey will be temporarily assigned as the "Common Name" if no IUPAC name or alternative short name is available.
**Note: the Chemical Classification was calculated by NPClassifier Version 1.5. Reference: PMID:34662515.

  Species Source

Organism ID Organism Name Taxonomy Level Family SuperKingdom Isolation Part Collection Location Collection Time Reference
NPO20471 Sophora alopecuroides Species Fabaceae Eukaryota root bark Mongolian n.a. PMID[26073007]
NPO20471 Sophora alopecuroides Species Fabaceae Eukaryota Aerial Parts n.a. n.a. PMID[31747283]
NPO20471 Sophora alopecuroides Species Fabaceae Eukaryota n.a. n.a. n.a. Database[HerDing]
NPO20471 Sophora alopecuroides Species Fabaceae Eukaryota n.a. n.a. n.a. Database[TCMID]
NPO20471 Sophora alopecuroides Species Fabaceae Eukaryota n.a. n.a. n.a. Database[TCM_Taiwan]
NPO20471 Sophora alopecuroides Species Fabaceae Eukaryota n.a. n.a. n.a. Database[UNPD]

☑ Note for Reference:
In addition to directly collecting NP source organism data from primary literature (where reference will provided as NCBI PMID or DOI links), NPASS also integrated them from below databases:
UNPD: Universal Natural Products Database [PMID: 23638153].
StreptomeDB: a database of streptomycetes natural products [PMID: 33051671].
TM-MC: a database of medicinal materials and chemical compounds in Northeast Asian traditional medicine [PMID: 26156871].
TCM@Taiwan: a Traditional Chinese Medicine database [PMID: 21253603].
TCMID: a Traditional Chinese Medicine database [PMID: 29106634].
TCMSP: The traditional Chinese medicine systems pharmacology database and analysis platform [PMID: 24735618].
HerDing: a herb recommendation system to treat diseases using genes and chemicals [PMID: 26980517].
MetaboLights: a metabolomics database [PMID: 27010336].
FooDB: a database of constituents, chemistry and biology of food species [www.foodb.ca].

  NP Quantity Composition/Concentration

Organism ID NP ID Organism Material Preparation Organism Part NP Quantity (Standard) NP Quantity (Minimum) NP Quantity (Maximum) Quantity Unit Reference

☑ Note for Reference:
In addition to directly collecting NP quantitative data from primary literature (where reference will provided as NCBI PMID or DOI links), NPASS also integrated NP quantitative records for specific NP domains (e.g., NPS from foods or herbs) from domain-specific databases. These databases include:
DUKE: Dr. Duke's Phytochemical and Ethnobotanical Databases.
PHENOL EXPLORER: is the first comprehensive database on polyphenol content in foods [PMID: 24103452], its homepage can be accessed at here.
FooDB: a database of constituents, chemistry and biology of food species [www.foodb.ca].

  Biological Activity

Target ID Target Type Target Name Target Organism Activity Type Activity Relation Value Unit Reference
NPT113 Cell Line RAW264.7 Mus musculus IC50 = 15900.0 nM PMID[480340]

☑ Note for Activity Records:
☉ The quantitative biological activities were primarily integrated from ChEMBL (Version-30) database and were also directly collected from PubMed literature. PubMed PMID was provided as the reference link for each activity record.

  Chemically structural similarity: I. Similar Active Natural Products in NPASS

Top-200 similar NPs were calculated against the active-NP-set (includes 4,3285 NPs with experimentally-derived bioactivity available in NPASS)

Similarity level is defined by Tanimoto coefficient (Tc) between two molecules. Tc lies between [0, 1] where '1' indicates the highest similarity. What is Tanimoto coefficient

●  The left chart: Distribution of similarity level between NPC473012 and all remaining natural products in the NPASS database.
●  The right table: Most similar natural products (Tc>=0.56 or Top200).

Similarity Score Similarity Level Natural Product ID
0.9935 High Similarity NPC312273
0.9935 High Similarity NPC301256
0.9935 High Similarity NPC473009
0.9871 High Similarity NPC473010
0.9615 High Similarity NPC473011
0.961 High Similarity NPC1796
0.961 High Similarity NPC257166
0.9557 High Similarity NPC251336
0.9548 High Similarity NPC15815
0.9548 High Similarity NPC51247
0.9542 High Similarity NPC121568
0.9487 High Similarity NPC42965
0.9487 High Similarity NPC98023
0.9487 High Similarity NPC195136
0.9487 High Similarity NPC226462
0.9484 High Similarity NPC475184
0.9481 High Similarity NPC79375
0.9481 High Similarity NPC37253
0.9423 High Similarity NPC105584
0.9419 High Similarity NPC32867
0.9419 High Similarity NPC69531
0.9412 High Similarity NPC178484
0.9363 High Similarity NPC121647
0.9359 High Similarity NPC208258
0.9359 High Similarity NPC323627
0.9359 High Similarity NPC318527
0.9359 High Similarity NPC324358
0.9359 High Similarity NPC287789
0.9359 High Similarity NPC322459
0.9359 High Similarity NPC271741
0.9355 High Similarity NPC134171
0.9355 High Similarity NPC182555
0.9355 High Similarity NPC300668
0.9355 High Similarity NPC66441
0.9351 High Similarity NPC115601
0.9351 High Similarity NPC78324
0.9351 High Similarity NPC208011
0.9351 High Similarity NPC39154
0.9321 High Similarity NPC477529
0.9304 High Similarity NPC18380
0.9299 High Similarity NPC51760
0.9299 High Similarity NPC295090
0.9295 High Similarity NPC61112
0.9295 High Similarity NPC198489
0.9281 High Similarity NPC3642
0.9255 High Similarity NPC286230
0.9255 High Similarity NPC253730
0.9245 High Similarity NPC15374
0.9241 High Similarity NPC292863
0.9241 High Similarity NPC184326
0.9231 High Similarity NPC265624
0.9231 High Similarity NPC14606
0.9231 High Similarity NPC201227
0.9231 High Similarity NPC159707
0.9231 High Similarity NPC258474
0.9231 High Similarity NPC186227
0.9231 High Similarity NPC205026
0.9231 High Similarity NPC150908
0.9231 High Similarity NPC158027
0.9231 High Similarity NPC215203
0.9231 High Similarity NPC52611
0.9231 High Similarity NPC100049
0.9231 High Similarity NPC121649
0.9231 High Similarity NPC248739
0.9226 High Similarity NPC43345
0.9226 High Similarity NPC174086
0.9216 High Similarity NPC122894
0.9193 High Similarity NPC171985
0.9193 High Similarity NPC320741
0.9193 High Similarity NPC224851
0.9187 High Similarity NPC38591
0.9182 High Similarity NPC137232
0.9177 High Similarity NPC18699
0.9177 High Similarity NPC55443
0.9177 High Similarity NPC195167
0.9172 High Similarity NPC309648
0.9172 High Similarity NPC56049
0.9172 High Similarity NPC54830
0.9167 High Similarity NPC71061
0.9167 High Similarity NPC290830
0.9167 High Similarity NPC303485
0.9167 High Similarity NPC72425
0.9167 High Similarity NPC324447
0.9167 High Similarity NPC194593
0.9161 High Similarity NPC476552
0.9161 High Similarity NPC476551
0.9161 High Similarity NPC476553
0.9156 High Similarity NPC132345
0.915 High Similarity NPC475348
0.915 High Similarity NPC261271
0.913 High Similarity NPC469664
0.913 High Similarity NPC169471
0.9097 High Similarity NPC472633
0.9091 High Similarity NPC152233
0.9091 High Similarity NPC145467
0.9091 High Similarity NPC300657
0.9085 High Similarity NPC290133
0.9085 High Similarity NPC24136
0.9085 High Similarity NPC470133
0.9085 High Similarity NPC473078
0.9085 High Similarity NPC109183
0.9085 High Similarity NPC228779
0.9085 High Similarity NPC470134
0.9085 High Similarity NPC187282
0.9085 High Similarity NPC470131
0.9085 High Similarity NPC470132
0.908 High Similarity NPC475212
0.908 High Similarity NPC107627
0.9074 High Similarity NPC82330
0.9068 High Similarity NPC290160
0.9068 High Similarity NPC63438
0.9062 High Similarity NPC273467
0.9062 High Similarity NPC189552
0.9057 High Similarity NPC123544
0.9051 High Similarity NPC208152
0.9051 High Similarity NPC78492
0.9048 High Similarity NPC150977
0.9038 High Similarity NPC204561
0.9038 High Similarity NPC309512
0.9038 High Similarity NPC67322
0.9038 High Similarity NPC317715
0.9038 High Similarity NPC222713
0.9038 High Similarity NPC148945
0.9038 High Similarity NPC138299
0.9038 High Similarity NPC78835
0.9038 High Similarity NPC111112
0.9038 High Similarity NPC316960
0.9036 High Similarity NPC101991
0.9032 High Similarity NPC473016
0.9026 High Similarity NPC308200
0.9024 High Similarity NPC279209
0.9024 High Similarity NPC102277
0.902 High Similarity NPC470136
0.902 High Similarity NPC194949
0.902 High Similarity NPC470135
0.902 High Similarity NPC235217
0.902 High Similarity NPC473014
0.902 High Similarity NPC271288
0.902 High Similarity NPC282957
0.902 High Similarity NPC39045
0.9012 High Similarity NPC477840
0.9006 High Similarity NPC261896
0.9006 High Similarity NPC310603
0.9 High Similarity NPC47905
0.9 High Similarity NPC312993
0.9 High Similarity NPC73929
0.9 High Similarity NPC139683
0.9 High Similarity NPC186325
0.8987 High Similarity NPC254351
0.8974 High Similarity NPC29777
0.8974 High Similarity NPC471115
0.8974 High Similarity NPC321896
0.8974 High Similarity NPC476185
0.897 High Similarity NPC257667
0.897 High Similarity NPC472454
0.897 High Similarity NPC186847
0.8968 High Similarity NPC106328
0.8968 High Similarity NPC168085
0.8968 High Similarity NPC35150
0.8968 High Similarity NPC39195
0.8963 High Similarity NPC53252
0.8963 High Similarity NPC300307
0.8961 High Similarity NPC127059
0.8961 High Similarity NPC285630
0.8961 High Similarity NPC472629
0.8954 High Similarity NPC107177
0.8954 High Similarity NPC77794
0.8954 High Similarity NPC278249
0.8954 High Similarity NPC223812
0.8954 High Similarity NPC185276
0.8954 High Similarity NPC85162
0.8954 High Similarity NPC125894
0.8954 High Similarity NPC81697
0.8951 High Similarity NPC159508
0.8944 High Similarity NPC92589
0.8944 High Similarity NPC142252
0.8941 High Similarity NPC304322
0.8938 High Similarity NPC90497
0.8938 High Similarity NPC472617
0.8938 High Similarity NPC177650
0.8938 High Similarity NPC40583
0.8931 High Similarity NPC192587
0.8929 High Similarity NPC121888
0.8924 High Similarity NPC213608
0.8924 High Similarity NPC1477
0.8917 High Similarity NPC472636
0.8916 High Similarity NPC24748
0.8916 High Similarity NPC17105
0.8916 High Similarity NPC474276
0.8916 High Similarity NPC147363
0.8916 High Similarity NPC73899
0.8916 High Similarity NPC59491
0.8916 High Similarity NPC168789
0.891 High Similarity NPC471114
0.891 High Similarity NPC317492
0.891 High Similarity NPC291746
0.891 High Similarity NPC288840
0.8909 High Similarity NPC287884
0.8909 High Similarity NPC180768
0.8909 High Similarity NPC8704

  Chemically structural similarity: II. Similar Clinical/Approved Drugs

Similarity level is defined by Tanimoto coefficient (Tc) between two molecules.

●  The left chart: Distribution of similarity level between NPC473012 and all drugs/candidates.
●  The right table: Most similar clinical/approved drugs (Tc>=0.56 or Top200).

Similarity Score Similarity Level Drug ID Developmental Stage
0.9355 High Similarity NPD8443 Clinical (unspecified phase)
0.9182 High Similarity NPD6959 Discontinued
0.8896 High Similarity NPD7852 Clinical (unspecified phase)
0.8805 High Similarity NPD2393 Clinical (unspecified phase)
0.8805 High Similarity NPD7819 Suspended
0.8696 High Similarity NPD7768 Phase 2
0.8679 High Similarity NPD7411 Suspended
0.8667 High Similarity NPD6166 Phase 2
0.8667 High Similarity NPD6167 Clinical (unspecified phase)
0.8667 High Similarity NPD6168 Clinical (unspecified phase)
0.8654 High Similarity NPD4378 Clinical (unspecified phase)
0.8654 High Similarity NPD7410 Clinical (unspecified phase)
0.8616 High Similarity NPD4380 Phase 2
0.8562 High Similarity NPD1550 Clinical (unspecified phase)
0.8562 High Similarity NPD1552 Clinical (unspecified phase)
0.8537 High Similarity NPD5494 Approved
0.8528 High Similarity NPD7075 Discontinued
0.8512 High Similarity NPD7804 Clinical (unspecified phase)
0.8509 High Similarity NPD1934 Approved
0.8506 High Similarity NPD1549 Phase 2
0.8353 Intermediate Similarity NPD7074 Phase 3
0.8344 Intermediate Similarity NPD7096 Clinical (unspecified phase)
0.8303 Intermediate Similarity NPD3749 Approved
0.8303 Intermediate Similarity NPD4381 Clinical (unspecified phase)
0.8294 Intermediate Similarity NPD7054 Approved
0.8284 Intermediate Similarity NPD7473 Discontinued
0.8258 Intermediate Similarity NPD2796 Approved
0.8256 Intermediate Similarity NPD6559 Discontinued
0.8246 Intermediate Similarity NPD7472 Approved
0.8242 Intermediate Similarity NPD4868 Clinical (unspecified phase)
0.8239 Intermediate Similarity NPD7390 Discontinued
0.8208 Intermediate Similarity NPD7808 Phase 3
0.8198 Intermediate Similarity NPD7993 Clinical (unspecified phase)
0.8194 Intermediate Similarity NPD1510 Phase 2
0.8161 Intermediate Similarity NPD8312 Approved
0.8161 Intermediate Similarity NPD8313 Approved
0.815 Intermediate Similarity NPD7251 Discontinued
0.8133 Intermediate Similarity NPD3882 Suspended
0.8129 Intermediate Similarity NPD3818 Discontinued
0.8125 Intermediate Similarity NPD1511 Approved
0.8121 Intermediate Similarity NPD2801 Approved
0.8107 Intermediate Similarity NPD6232 Discontinued
0.8101 Intermediate Similarity NPD2800 Approved
0.8092 Intermediate Similarity NPD6797 Phase 2
0.8081 Intermediate Similarity NPD5844 Phase 1
0.8075 Intermediate Similarity NPD2534 Approved
0.8075 Intermediate Similarity NPD2533 Approved
0.8075 Intermediate Similarity NPD2532 Approved
0.8061 Intermediate Similarity NPD6801 Discontinued
0.8052 Intermediate Similarity NPD1240 Approved
0.8039 Intermediate Similarity NPD4907 Clinical (unspecified phase)
0.8025 Intermediate Similarity NPD1512 Approved
0.7987 Intermediate Similarity NPD7421 Clinical (unspecified phase)
0.7964 Intermediate Similarity NPD3817 Phase 2
0.7949 Intermediate Similarity NPD1607 Approved
0.7944 Intermediate Similarity NPD7879 Clinical (unspecified phase)
0.7925 Intermediate Similarity NPD970 Clinical (unspecified phase)
0.7908 Intermediate Similarity NPD4908 Phase 1
0.7898 Intermediate Similarity NPD4419 Clinical (unspecified phase)
0.7853 Intermediate Similarity NPD7004 Clinical (unspecified phase)
0.7834 Intermediate Similarity NPD6651 Approved
0.7833 Intermediate Similarity NPD8397 Clinical (unspecified phase)
0.7826 Intermediate Similarity NPD3750 Approved
0.7799 Intermediate Similarity NPD2935 Discontinued
0.7799 Intermediate Similarity NPD6100 Approved
0.7799 Intermediate Similarity NPD6099 Approved
0.7798 Intermediate Similarity NPD8455 Phase 2
0.7797 Intermediate Similarity NPD4338 Clinical (unspecified phase)
0.7791 Intermediate Similarity NPD6799 Approved
0.7791 Intermediate Similarity NPD7229 Phase 3
0.7771 Intermediate Similarity NPD3226 Approved
0.7758 Intermediate Similarity NPD920 Approved
0.7751 Intermediate Similarity NPD5402 Approved
0.775 Intermediate Similarity NPD2344 Approved
0.7725 Intermediate Similarity NPD6599 Discontinued
0.7692 Intermediate Similarity NPD6859 Clinical (unspecified phase)
0.7665 Intermediate Similarity NPD5808 Clinical (unspecified phase)
0.7663 Intermediate Similarity NPD4363 Phase 3
0.7663 Intermediate Similarity NPD4360 Phase 2
0.7654 Intermediate Similarity NPD1243 Approved
0.7651 Intermediate Similarity NPD5403 Approved
0.7644 Intermediate Similarity NPD3926 Phase 2
0.7636 Intermediate Similarity NPD642 Clinical (unspecified phase)
0.7625 Intermediate Similarity NPD2799 Discontinued
0.7625 Intermediate Similarity NPD1509 Clinical (unspecified phase)
0.7622 Intermediate Similarity NPD643 Clinical (unspecified phase)
0.7607 Intermediate Similarity NPD6398 Clinical (unspecified phase)
0.7604 Intermediate Similarity NPD8151 Discontinued
0.7586 Intermediate Similarity NPD5711 Approved
0.7586 Intermediate Similarity NPD5710 Approved
0.7584 Intermediate Similarity NPD5953 Discontinued
0.7581 Intermediate Similarity NPD8090 Clinical (unspecified phase)
0.7579 Intermediate Similarity NPD7871 Phase 2
0.7579 Intermediate Similarity NPD7870 Phase 2
0.7578 Intermediate Similarity NPD1551 Phase 2
0.7571 Intermediate Similarity NPD7286 Phase 2
0.7569 Intermediate Similarity NPD8055 Clinical (unspecified phase)
0.7561 Intermediate Similarity NPD2309 Approved
0.756 Intermediate Similarity NPD7458 Discontinued
0.7545 Intermediate Similarity NPD6980 Clinical (unspecified phase)
0.7531 Intermediate Similarity NPD2346 Discontinued
0.753 Intermediate Similarity NPD5401 Approved
0.7529 Intermediate Similarity NPD1247 Approved
0.7529 Intermediate Similarity NPD7199 Phase 2
0.7527 Intermediate Similarity NPD8150 Discontinued
0.7526 Intermediate Similarity NPD7697 Approved
0.7526 Intermediate Similarity NPD7696 Phase 3
0.7526 Intermediate Similarity NPD7698 Approved
0.7516 Intermediate Similarity NPD3748 Approved
0.7514 Intermediate Similarity NPD7228 Approved
0.7514 Intermediate Similarity NPD919 Approved
0.7486 Intermediate Similarity NPD3787 Discontinued
0.7485 Intermediate Similarity NPD1465 Phase 2
0.7471 Intermediate Similarity NPD7615 Clinical (unspecified phase)
0.7469 Intermediate Similarity NPD5405 Approved
0.7469 Intermediate Similarity NPD5406 Approved
0.7469 Intermediate Similarity NPD5404 Approved
0.7469 Intermediate Similarity NPD5408 Approved
0.746 Intermediate Similarity NPD6780 Approved
0.746 Intermediate Similarity NPD6779 Approved
0.746 Intermediate Similarity NPD6777 Approved
0.746 Intermediate Similarity NPD6776 Approved
0.746 Intermediate Similarity NPD6782 Approved
0.746 Intermediate Similarity NPD6781 Approved
0.746 Intermediate Similarity NPD6778 Approved
0.7451 Intermediate Similarity NPD1610 Phase 2
0.7443 Intermediate Similarity NPD7184 Clinical (unspecified phase)
0.7436 Intermediate Similarity NPD7782 Clinical (unspecified phase)
0.7436 Intermediate Similarity NPD7783 Phase 2
0.7435 Intermediate Similarity NPD7435 Discontinued
0.7433 Intermediate Similarity NPD4362 Clinical (unspecified phase)
0.7433 Intermediate Similarity NPD4361 Phase 2
0.7432 Intermediate Similarity NPD8434 Phase 2
0.7427 Intermediate Similarity NPD37 Approved
0.7425 Intermediate Similarity NPD7422 Clinical (unspecified phase)
0.7416 Intermediate Similarity NPD3751 Discontinued
0.7414 Intermediate Similarity NPD6234 Discontinued
0.7399 Intermediate Similarity NPD4966 Approved
0.7399 Intermediate Similarity NPD4965 Approved
0.7399 Intermediate Similarity NPD4967 Phase 2
0.7394 Intermediate Similarity NPD7003 Approved
0.7394 Intermediate Similarity NPD4628 Phase 3
0.7389 Intermediate Similarity NPD2861 Phase 2
0.7384 Intermediate Similarity NPD5761 Phase 2
0.7384 Intermediate Similarity NPD5760 Phase 2
0.7381 Intermediate Similarity NPD6273 Approved
0.7371 Intermediate Similarity NPD7701 Phase 2
0.7368 Intermediate Similarity NPD7501 Clinical (unspecified phase)
0.7358 Intermediate Similarity NPD2313 Discontinued
0.7351 Intermediate Similarity NPD4287 Approved
0.7347 Intermediate Similarity NPD7801 Approved
0.7342 Intermediate Similarity NPD6832 Phase 2
0.7338 Intermediate Similarity NPD1547 Clinical (unspecified phase)
0.7329 Intermediate Similarity NPD5123 Clinical (unspecified phase)
0.7329 Intermediate Similarity NPD5124 Phase 1
0.7318 Intermediate Similarity NPD7893 Clinical (unspecified phase)
0.7318 Intermediate Similarity NPD7177 Discontinued
0.7317 Intermediate Similarity NPD2343 Clinical (unspecified phase)
0.7301 Intermediate Similarity NPD7033 Discontinued
0.7296 Intermediate Similarity NPD4625 Phase 3
0.7296 Intermediate Similarity NPD7874 Approved
0.7296 Intermediate Similarity NPD7875 Clinical (unspecified phase)
0.7292 Intermediate Similarity NPD6823 Phase 2
0.7289 Intermediate Similarity NPD1878 Clinical (unspecified phase)
0.7267 Intermediate Similarity NPD1613 Approved
0.7267 Intermediate Similarity NPD943 Approved
0.7267 Intermediate Similarity NPD1612 Clinical (unspecified phase)
0.7263 Intermediate Similarity NPD7699 Phase 2
0.7263 Intermediate Similarity NPD7700 Phase 2
0.7262 Intermediate Similarity NPD6143 Clinical (unspecified phase)
0.725 Intermediate Similarity NPD3268 Approved
0.725 Intermediate Similarity NPD6410 Clinical (unspecified phase)
0.7232 Intermediate Similarity NPD8127 Discontinued
0.7231 Intermediate Similarity NPD7584 Approved
0.7225 Intermediate Similarity NPD6844 Discontinued
0.7216 Intermediate Similarity NPD8319 Approved
0.7216 Intermediate Similarity NPD8320 Phase 1
0.7215 Intermediate Similarity NPD2798 Approved
0.7196 Intermediate Similarity NPD6535 Approved
0.7196 Intermediate Similarity NPD6534 Approved
0.7179 Intermediate Similarity NPD1608 Approved
0.7158 Intermediate Similarity NPD7685 Pre-registration
0.7158 Intermediate Similarity NPD7240 Approved
0.7152 Intermediate Similarity NPD1203 Approved
0.7152 Intermediate Similarity NPD2797 Approved
0.7143 Intermediate Similarity NPD1729 Discontinued
0.7143 Intermediate Similarity NPD3764 Approved
0.7134 Intermediate Similarity NPD4749 Approved
0.7134 Intermediate Similarity NPD7097 Phase 1
0.7126 Intermediate Similarity NPD7577 Discontinued
0.7126 Intermediate Similarity NPD2654 Approved
0.7125 Intermediate Similarity NPD1529 Clinical (unspecified phase)
0.7118 Intermediate Similarity NPD7447 Phase 1
0.7117 Intermediate Similarity NPD1899 Clinical (unspecified phase)
0.7117 Intermediate Similarity NPD6355 Discontinued
0.7115 Intermediate Similarity NPD1201 Approved
0.7108 Intermediate Similarity NPD6005 Phase 3
0.7108 Intermediate Similarity NPD6006 Clinical (unspecified phase)
0.7108 Intermediate Similarity NPD6004 Phase 3
0.7108 Intermediate Similarity NPD6003 Clinical (unspecified phase)

  Bioactivity similarity: Similar Natural Products in NPASS

Bioactivity similarity was calculated based on bioactivity descriptors of compounds. The bioactivity descriptors were calculated by a recently developed AI algorithm Chemical Checker (CC) [Nature Biotechnology, 38:1087–1096, 2020; Nature Communications, 12:3932, 2021], which evaluated bioactivity similarities at five levels:
A: chemistry similarity;
B: biological targets similarity;
C: networks similarity;
D: cell-based bioactivity similarity;
E: similarity based on clinical data.

Those 5 categories of CC bioactivity descriptors were calculated and then subjected to manifold projection using UMAP algorithm, to project all NPs on a 2-Dimensional space. The current NP was highlighted with a small circle in the 2-D map. Below figures: left-to-right, A-to-E.

A: chemistry similarity
B: biological targets similarity
C: networks similarity
D: cell-based bioactivity similarity
E: similarity based on clinical data